- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01018589
Cicatrix Cream in Post Surgical Scars and Epidermic Burn
December 7, 2010 updated by: Catalysis SL
Effect the Cicatrix Cream in in Treatment of Post Surgical Scars and and Epidermic Burn.
The purpose of the study is to assess the effect of CICATRIX (Asian Gotu Kola or Pennywort) usage in the treatment of epidermic burns or post surgical scars.
The duration of this phase 2 clinical trial will be two months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Havana
-
Havana City, Havana, Cuba, 10400
- Juan Manuel Marquez Pediatric Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 16 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient with lesions characteristic of the investigated illness.
- Signed informed consent
Exclusion Criteria:
- Patient that refer manifestations of high sensibility to the medication or to some of the components of the product
- Patient that don't want to participate in the study
- Patient not very cooperative
- Family responsible not very cooperative
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: A
Cicatrix cream
|
We will be carried out the topical application of the product (Cicatrix cream) in the epidermic burns or post surgical scars by administration fo the patients twice a day during two months to a dose of 0,1 ml of cream for each cm of surface, being controlled by the specialist in biweekly consultations. To the patient will be explained the technique of the application. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Reduction of the areas of lesions at 2 months (end of the treatment)
Time Frame: 2 months
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Coloration of the lesions at 2 months (end of the treatment)
Time Frame: 2 months
|
2 months
|
Adverse effects
Time Frame: 2 months
|
2 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Edelisa Moredo Romo, MD, Juan Manuel Marquez Pediatric Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2009
Primary Completion (Actual)
December 1, 2010
Study Completion (Actual)
December 1, 2010
Study Registration Dates
First Submitted
November 20, 2009
First Submitted That Met QC Criteria
November 20, 2009
First Posted (Estimate)
November 23, 2009
Study Record Updates
Last Update Posted (Estimate)
December 8, 2010
Last Update Submitted That Met QC Criteria
December 7, 2010
Last Verified
December 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CAT-0904-CU
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Surgical Scars
-
Catalysis SLCompleted
-
University of LouisvilleCompleted
-
Henry Ford Health SystemAmerican Academy of Cosmetic SurgeryCompletedPost Surgical ScarsUnited States
-
Cynosure, Inc.Terminated
-
University Hospital, GhentCompleted
-
University Hospital, GhentCompletedScars After Surgical InterventionBelgium
-
University of British ColumbiaUnknown
-
Merz Pharmaceuticals GmbHCompletedPost Dermatological Surgery ScarsGermany
-
IHU StrasbourgRhythm Diagnostic SystemsCompletedVisceral and Digestive Surgery | Post-surgical Monitoring | Post-surgical RehabilitationFrance
-
Sheikh Zayed Medical CollegeNot yet recruitingPost-Surgical Complication
Clinical Trials on Cicatrix cream
-
Catalysis SLCompleted
-
Catalysis SLCompleted
-
University of North Carolina, CharlotteTeva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States
-
Incyte CorporationCompletedCutaneous Lichen PlanusUnited States, Canada
-
Incyte CorporationRecruitingPrurigoUnited States, Spain, France, Poland, Germany, Belgium, Netherlands, Argentina, Italy, Canada, Chile, Brazil
-
Edesa Biotech Inc.JSS Medical Research Inc.Active, not recruitingAllergic Contact DermatitisUnited States, Canada
-
LEO PharmaCompletedChronic Hand EczemaUnited States, Germany, Denmark
-
LEO PharmaCompletedHealthy VolunteersGermany
-
Incyte CorporationCompletedHidradenitis SuppurativaUnited States, Canada